Keros Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $473k | 12k | 39.76 |
| 2023-09-30 | $379k | 12k | 31.88 |
| 2023-06-30 | $478k | 12k | 40.18 |
| 2023-03-31 | $431k | 10k | 42.70 |
| 2022-12-31 | $485k | 10k | 48.02 |
| 2022-09-30 | $318k | 8.5k | 37.62 |
| 2022-06-30 | $234k | 8.5k | 27.63 |
| 2022-03-31 | $460k | 8.5k | 54.41 |
| 2021-12-31 | $319k | 5.5k | 58.47 |
| 2021-09-30 | $216k | 5.5k | 39.56 |
| 2021-06-30 | $232k | 5.5k | 42.52 |
| 2021-03-31 | $336k | 5.5k | 61.58 |
| 2020-12-31 | $385k | 5.5k | 70.56 |
| 2020-09-30 | $147k | 3.8k | 38.58 |
| 2020-06-30 | $143k | 3.8k | 37.53 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors